MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M

Stock Information for MediPharm Labs Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About MediPharm Labs Corp.

MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health
MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
MediPharm Labs Reports Third Quarter Results
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
MediPharm Labs Announces $2.1M Debt Repayment
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.